New hope for advanced throat cancer: trial tests powerful drug combo
NCT ID NCT03734809
Summary
This study is testing a new treatment approach for people with advanced nasopharyngeal cancer (a type of throat cancer). It combines an immunotherapy drug (pembrolizumab) with standard chemotherapy and radiation, aiming to better control the cancer and prevent it from spreading. The goal is to see if this combination is safe and more effective than current treatments for patients with high-risk, locally advanced disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NPC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Department of Clinical Oncology, Prince of Wales Hospital
Hong Kong, Hong Kong
-
National Cancer Centre of Singapore
Singapore, Singapore
Conditions
Explore the condition pages connected to this study.